KIR2DL2/3-HLA-C-group 1 and KIR2DL1-HLA-C-group 2 mismatches improve the clinical outcome in patients with acute myelogenous leukaemia after allogeneic stem cell transplantation

被引：0
|
作者：
Richter, R. [1 ]
Bug, G. [1 ]
Mousset, S. [1 ]
Seifried, E. [1 ]
Serve, H. [1 ]
Seidl, C. [1 ]
Martin, H. [1 ]
机构：
[1] Goethe Univ Frankfurt, Frankfurt, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [1] KIR2DL2/3-HLA-C-Group1 and KIR2DL1-HLA-C-Group2 mismatches improve the clinical outcome in patients with acute myelogenous leukaemia after allogeneic stem cell transplantation
    Richter, R.
    Bug, G.
    Mousset, S.
    Seifried, E.
    Serve, H.
    Seidl, C.
    Martin, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S270 - S270
  • [2] Improved survival after stem allogeneic transplantation due to KIR2DL2/3-HLA-C-group 1 and KIR2DL1-HLA-C-group 2 mismatches in patients with acute myeloid leukemia
    Richter, R.
    Bug, G.
    Mousset, S.
    Serve, H.
    Seifried, E.
    Seidl, C.
    Martin, H.
    ONKOLOGIE, 2011, 34 : 285 - 286
  • [3] DIFFERENTIAL REGULATION OF THE KIR2DL1+, KIR2DL2/3+, AND KIR3DL1+NK CELL ACTIVITY ACCORDING TO THE KIR HLA LIGAND MECHANISM
    Richter, Rudolf
    Becker, Petra S. A.
    Dombos, Sara
    Hennecke, Johannes F.
    Seifried, Erhard
    Seidl, Christian
    TISSUE ANTIGENS, 2013, 81 (05): : 293 - 294
  • [4] Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
    Roberts, Chrissy H.
    Molina, Sandra
    Makalo, Pateh
    Joof, Hassan
    Harding-Esch, Emma M.
    Burr, Sarah E.
    Mabey, David C. W.
    Bailey, Robin L.
    Burton, Matthew J.
    Holland, Martin J.
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (03):
  • [5] Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
    Erbe, Amy K.
    Wang, Wei
    Carmichael, Lakeesha
    Hoefges, Anna
    Grzywacz, Bartosz
    Reville, Patrick K.
    Ranheim, Erik A.
    Hank, Jacquelyn A.
    Kim, KyungMann
    Seo, Songwon
    Mendonca, Eneida A.
    Song, Yiqiang
    Kenkre, Vaishalee P.
    Hong, Fangxin
    Gascoyne, Randy D.
    Paietta, Elisabeth
    Horning, Sandra J.
    Miller, Jeffrey S.
    Kahl, Brad
    Sondel, Paul M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
    Shoeib Moradi
    Sanda Stankovic
    Geraldine M. O’Connor
    Phillip Pymm
    Bruce J. MacLachlan
    Camilla Faoro
    Christelle Retière
    Lucy C. Sullivan
    Philippa M. Saunders
    Jacqueline Widjaja
    Shea Cox-Livingstone
    Jamie Rossjohn
    Andrew G. Brooks
    Julian P. Vivian
    Nature Communications, 12
  • [7] Susceptibility to Crohn’s disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand
    Jill A. Hollenbach
    Martha B. Ladner
    Koy Saeteurn
    Kent D. Taylor
    Ling Mei
    Talin Haritunians
    Dermot P. B. McGovern
    Henry A. Erlich
    Jerome I. Rotter
    Elizabeth A. Trachtenberg
    Immunogenetics, 2009, 61 : 663 - 671
  • [8] Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
    Moradi, Shoeib
    Stankovic, Sanda
    O'Connor, Geraldine M.
    Pymm, Phillip
    MacLachlan, Bruce J.
    Faoro, Camilla
    Retiere, Christelle
    Sullivan, Lucy C.
    Saunders, Philippa M.
    Widjaja, Jacqueline
    Cox-Livingstone, Shea
    Rossjohn, Jamie
    Brooks, Andrew G.
    Vivian, Julian P.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [9] Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
    Vivian, Julian P.
    Moradi, Shoeib
    Stankovich, Sanda
    O'connor, Geraldine
    Rossjohn, Jamie
    Brooks, Andrew
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 67 - 67
  • [10] Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand
    Hollenbach, Jill A.
    Ladner, Martha B.
    Saeteurn, Koy
    Taylor, Kent D.
    Mei, Ling
    Haritunians, Talin
    McGovern, Dermot P. B.
    Erlich, Henry A.
    Rotter, Jerome I.
    Trachtenberg, Elizabeth A.
    IMMUNOGENETICS, 2009, 61 (10) : 663 - 671
12345